Net Assets for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's latest reported net assets is $1.61B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$1.61B
YoY change
+0.6%
5Y CAGR
+20.5%
Peak year (2025)
$1.61B
Latest annual
$1.61B
Net Assets history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Net Assets history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $1.61B | +0.6% | ||
| 2024 | $1.60B | +7.5% | ||
| 2023 | $1.48B | +143.9% | ||
| 2022 | $608.74M | -11.8% | ||
| 2021 | $689.99M | +9.2% | ||
| 2020 | $632.09M | +256.2% | ||
| 2019 | $177.47M | -1965.6% | ||
| 2018 | -$9.51M | -82.4% | ||
| 2017 | -$54.11M | -50.1% | ||
| 2016 | -$108.35M | +28.8% | ||
| 2015 | -$84.13M | -171.6% | ||
| 2014 | $117.52M | -77.3% | ||
| 2013 | $518.19M | -18.6% | ||
| 2012 | $636.22M | +17.9% | ||
| 2011 | $539.58M | -6.0% | ||
| 2010 | $574.24M | +11.6% | ||
| 2009 | $514.57M | +17.4% | ||
| 2008 | $438.19M | -0.0% | ||
| 2007 | $438.32M | +6.9% | ||
| 2006 | $409.86M | +11.1% | ||
| 2005 | $369.01M | -7.2% | ||
| 2004 | $397.66M | -3.8% | ||
| 2003 | $413.29M | +21.2% | ||
| 2002 | $340.97M | +13.0% | ||
| 2001 | $301.73M | +15.3% | ||
| 2000 | $261.75M | -7.9% | ||
| 1999 | $284.30M | -7.6% | ||
| 1998 | $307.80M | +1.7% | ||
| 1997 | $302.70M | -6.2% | ||
| 1996 | $322.70M | +15.6% | ||
| 1995 | $279.10M | +179.7% | ||
| 1994 | $99.80M | +19.4% | ||
| 1993 | $83.60M | +18.8% | ||
| 1992 | $70.40M | +123.5% | ||
| 1991 | $31.50M | — |
Net Assets values are taken from IDEXX Laboratories's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, IDEXX Laboratories (IDXX) net assets totalled $1.61B – edged up 0.6% year-over-year.
Over 2020–2025 (5 years), IDEXX Laboratories net assets expanded at a +20.5% compound annual rate, sustaining 3 straight years of year-over-year growth.
$1.61B stands as the all-time-high annual net assets, posted in 2025, against a low of -$108.35M during 2016.
Among 8 Healthcare peers, IDEXX Laboratories (IDXX) ranks 8th; the peer median for net assets is $50.64B.
IDEXX Laboratories Net Assets by Year
IDEXX Laboratories Net Assets 2025: $1.61B
IDEXX Laboratories net assets in 2025 was $1.61B, edged up 0.6% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Net Assets 2024: $1.60B
IDEXX Laboratories net assets in 2024 was $1.60B, grew 7.5% from 2023.
IDEXX Laboratories Net Assets 2023: $1.48B
IDEXX Laboratories net assets in 2023 was $1.48B, surged 143.9% from 2022.
IDEXX Laboratories Net Assets 2022: $608.74M
IDEXX Laboratories net assets in 2022 was $608.74M, declined 11.8% below 2021.
IDEXX Laboratories Net Assets 2021: $689.99M
IDEXX Laboratories net assets in 2021 was $689.99M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Net Assets
Companies in the same sector as IDEXX Laboratories, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's net assets?
- Latest reported net assets for IDEXX Laboratories (IDXX) is $1.61B (period ending December 31, 2025).
How has IDEXX Laboratories net assets changed year-over-year?
- IDEXX Laboratories (IDXX) net assets changed +0.6% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories net assets?
- IDEXX Laboratories (IDXX) net assets compound annual growth rate is +20.5% over the most recent 5 years available.
When did IDEXX Laboratories net assets hit its highest annual value?
- IDEXX Laboratories net assets reached its highest annual value of $1.61B in 2025.
What was IDEXX Laboratories net assets in 2024?
- IDEXX Laboratories (IDXX) net assets in 2024 was $1.60B.
What was IDEXX Laboratories net assets in 2025?
- IDEXX Laboratories (IDXX) net assets in 2025 was $1.61B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.